Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.

GREY:ISOLF - Post by User

Isodiol International Inc

Bullboard Posts

Post by Kevelleon Aug 03, 2018 12:02pm

58 Views

Post# 28410744

United Kingdom’s Medicines and Healthcare Products Regulator

As a GMP certified facility, Isodiol’s subsidiary BSPG Laboratories LTD. has received government approval from the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA), in accordance with The Human Medicines Regulations 2012 (SI 2012/1916), for the manufacturing of CBD under certificate number: UK API 48727.

“We’re excited to secure this pharmaceutical grade source of U.K. manufactured CBD from Isodiol at a time when new local British and regional European opportunities are presenting themselves by the day,” said Pure Global President & CEO, Malay Panchal. “Notwithstanding the growing demand for CBD in Canada and our plans for pharma and nutraceutical grade imports, we call ourselves ‘Global’ for a reason. This is the first of a number of strategic initiatives which will help propel our international vision forward.”